Evidence map›Paper›PMID 28111861›Full record

Trial reportAmerican journal of reproductive immunology (New York, N.Y. : 1989)2017

Comparison of sampling methods to measure HIV RNA viral load in female genital tract secretions.

Shameem Z Jaumdally, Heidi E Jones, Donald R Hoover, Hoyam Gamieldien, Jean-Mari Kriek, Nontokozo Langwenya, Landon Myer, Jo-Ann S Passmore, Catherine S Todd

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of reproductive immunology (New York, N.Y. : 1989), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. UnveilingiScience · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Shameem Z JaumdallyDivision of Medical Virology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Heidi E JonesDepartment of Epidemiology and Biostatistics, City University of New York Graduate School of Public Health & Health Policy, New York, NY, USA.
Donald R HooverDepartment of Statistics & Biostatistics, Rutgers The State University, Piscataway, NJ, USA.
Hoyam GamieldienDivision of Medical Virology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Jean-Mari KriekDivision of Medical Virology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Nontokozo LangwenyaDivision of Epidemiology & Biostatistics and Centre for Infectious Diseases Epidemiology & Research School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Landon MyerDivision of Epidemiology & Biostatistics and Centre for Infectious Diseases Epidemiology & Research School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Jo-Ann S PassmoreDivision of Medical Virology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Catherine S ToddFHI 360, Durham, NC, USA.
University of Cape Town · ZACity University of New York · USFamily Health International 360 · USRutgers, The State University of New Jersey · US

Funding

Safety and Acceptability of Two IUDs among Cape Town HIV-positive Women: A RCTR01HD071804 · NICHD · FAMILY HEALTH INTERNATIONAL · PI MYER, BENJAMIN LANDON, TODD, CATHERINE SUZANNE · 2012 to 2017
$2.6M
NICHD NIH HHS R01 HD071804
6 · The paper itself

Abstract

problemHow does menstrual cup (MC) compare to other genital sampling methods for HIV RNA recovery? METHOD OF STUDY: We compared HIV RNA levels between MC, endocervical swab (ECS), and ECS-enriched cervicovaginal lavage (eCVL) specimens in 51 HIV-positive, antiretroviral therapy-naive women at enrollment, 3 and 6 months, with order rotated by visit. Paired comparisons were analyzed with McNemar's exact tests, signed-rank tests, and an extension of Somer's D for pooled analyses across visits.

resultsMC specimens had the highest proportion of quantifiable HIV VL at enrollment and month 3, but more MC specimens (n=12.8%) were insufficient for testing, compared with ECS (2%, P=0.006) and eCVL (0%, P<0.001). Among sufficient specimens, median VL was significantly higher for MC (2.62 log

conclusionMC may be more sensitive than eCVL and CVS, provided insufficient specimens are reduced.

Indexed as

Hygiene ProductsAdolescentAdultDouble-Blind MethodFemaleGenitalia, FemaleHIV-1HIV InfectionsHumansIntrauterine DevicesMenstruationRNA, ViralSpecimen HandlingViral LoadYoung AdultHygiene ProductsRNA, Viralcervicovaginal lavageendocervical swabfemale genital tract samplinggenital HIV viral loadmenstrual cup

Identifiers

PMID28111861
PMCPMC6457130
OpenAlexW2581682651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.